Drugplain

HyperRAB 300 [iU]/mL

Rabies Immune Globulin (Human) · INJECTION, SOLUTION · GRIFOLS USA, LLC

No Recall History
Plain English

HyperRAB is a injection, solution containing rabies immune globulin (human) at 300 [iU]/mL, taken infiltration. Manufactured by GRIFOLS USA, LLC.

Key Facts

Brand Name
HyperRAB
Generic Name
Rabies Immune Globulin (Human)
NDC Code (Product)
13533-318
Manufacturer
GRIFOLS USA, LLC
Strength
300 [iU]/mL
Dosage Form
INJECTION, SOLUTION
Route
INFILTRATION, INTRAMUSCULAR
Marketing Status
Application #
BLA101144
Marketing Start
06/12/1974

Recall History

No Recall History

Frequently Asked Questions

What is HyperRAB used for?

HyperRAB contains Rabies Immune Globulin (Human). It is a injection, solution taken infiltration. Consult your doctor for specific uses.

Is HyperRAB a controlled substance?

HyperRAB is not classified as a controlled substance by the DEA.

What is the generic name for HyperRAB?

The generic name for HyperRAB is Rabies Immune Globulin (Human). There are 1 other brand versions of Rabies Immune Globulin (Human).

What is the NDC code for HyperRAB 300 [iU]/mL?

The NDC (National Drug Code) for HyperRAB 300 [iU]/mL is 13533-318, listed by GRIFOLS USA, LLC.

Product NDC

13533-318

Package NDC

13533-318-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)